PARICALCITOL

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C27H44O3
Molecular Weight	416.6365
Optical Activity	UNSPECIFIED
Defined Stereocenters	7 / 7
E/Z Centers	2
Charge	0

SHOW SMILES / InChI

Structure of PARICALCITOL

Structure Search

SMILES

[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C3C[C@@H](O)C[C@H](O)C3)[C@H](C)\C=C\[C@H](C)C(C)(C)O

InChI

InChIKey=BPKAHTKRCLCHEA-UBFJEZKGSA-N

InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C27H44O3
Molecular Weight	416.6365
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	7 / 7
E/Z Centers	2
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:53:27 UTC 2023` Edited by `admin` on `Fri Dec 15 15:53:27 UTC 2023`
Record UNII	6702D36OG5
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PARICALCITOL

Official Name

English

PARICALCITOL [MART.]

Common Name

English

PARICALCITOL [USP IMPURITY]

Common Name

English

PARICALCITOL [MI]

Common Name

English

(7E,22E)-19-NOR-9,10-SECOERGOSTA-5,7,22-TRIENE-1.ALPHA.,3.BETA.,25-TRIOL

Common Name

English

COMPOUND 49510

Code

English

PARICALCITOL [VANDF]

Common Name

English

PARICALCITOL [USAN]

Common Name

English

PARICALCITOL [USP-RS]

Common Name

English

Paricalcitol [WHO-DD]

Common Name

English

(1.ALPHA.3.BETA.,7E,22E)-19-NOR-9,10-SECOERGOSTA-5,7,22-TRIENE-1,3,25-TRIOL

Common Name

English

PARICALCITOL [USP MONOGRAPH]

Common Name

English

ZEMPLAR

Brand Name

English

PARICALCITOL [ORANGE BOOK]

Common Name

English

COMPOUND-49510

Code

English

PARICALCITOL [HSDB]

Common Name

English

PARICALCITOL [JAN]

Common Name

English

Classification Tree Code System Code

NDF-RT

N0000006996

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

WHO-VATC

QH05BX02

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

NDF-RT

N0000175908

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

NCI_THESAURUS

C39713

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

LIVERTOX

740

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

NDF-RT

N0000006996

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

NDF-RT

N0000006996

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

FDA ORPHAN DRUG

492815

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

NDF-RT

N0000006996

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

WHO-ATC

H05BX02

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

Code System Code Type Description

FDA UNII

6702D36OG5

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

DRUG BANK

DB00910

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

HSDB

7360

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

EPA CompTox

DTXSID4048640

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

INN

7688

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

NCI_THESAURUS

C38693

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

USAN

JJ-08

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

PUBCHEM

5281104

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

RS_ITEM_NUM

1499403

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

SMS_ID

100000092510

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

DRUG CENTRAL

2066

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

CAS

131918-61-1

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

MESH

C084656

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

EVMPD

SUB09627MIG

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

CHEBI

7931

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

MERCK INDEX

m8413

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

Merck Index

DAILYMED

6702D36OG5

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

RXCUI

73710

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

RxNorm

ChEMBL

CHEMBL1200622

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

IUPHAR

2791

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

WIKIPEDIA

PARICALCITOL

Created by admin on Fri Dec 15 15:53:27 UTC 2023 , Edited by admin on Fri Dec 15 15:53:27 UTC 2023

PRIMARY

Related Record Type Details


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					UD6C4246PU

VITAMIN D3 RECEPTOR

TARGET -> AGONIST

Amount:

Related Record Type Details


					6702D36OG5

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC				Stage 5 CDK: IV PHARMACOKINETIC Stage 3 and 4 CDK: Oral PHARMACOKINETIC Healthy Subjects: IV PHARMACOKINETIC Healthy Subjects: Oral PHARMACOKINETIC Stage 5 CDK: Oral PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC				Elimination: Healthy Subjects: IV PHARMACOKINETIC Elimination: Stage 5 CKD(On HD or PD): IV PHARMACOKINETIC Elimination: Healthy Subjects: Oral PHARMACOKINETIC Elimination: Stage 5 CKD(On HD or PD): Oral PHARMACOKINETIC Elimination: Stage 3 and 4 CKD: Oral PHARMACOKINETIC